glp-1 market news november 2025 Pipeline Update: - Prime Therapeutics GLP-1 Receptor Agonist Market Forecast

Below are some brief details of these drug molecules- Glucagon like peptide1 (GLP1) and gastric inhibitory polypeptide (GIP) are hormones that help regulate blood sugar after meals

In such cases, starting an oral GLP-1 medication may reduce hesitation and improve early engagement with therapy

Orforglipron 3 mg, 12 mg, and 36 mg Convenience of daily oral administration Orforglipron, the novel oral GLP-1 receptor agonist by Eli Lilly, offers significant benefits for weight loss through its convenient once-daily pill formulation, eliminating the need for injections commonly associated with similar medications like semaglutide or Wegovy

Defective signaling through Akt-2 and-3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance

doi:10.1001/jama.2025.14392

Access and affordability constraints limit the population that can benefit from current therapies